On Monday, RAPT Therapeutics Inc (NASDAQ: RAPT) opened lower -39.45% from the last session, before settling in for the closing price of $2.89. Price fluctuations for RAPT have ranged from $1.64 to $27.35 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -36.87%. Company’s average yearly earnings per share was noted 17.89% at the time writing. With a float of $31.00 million, this company’s outstanding shares have now reached $34.40 million.
Let’s determine the extent of company efficiency that accounts for 131 employees. In terms of profitability, gross margin is 65.02%, operating margin of -2439.18%, and the pretax margin is -2277.44%.
RAPT Therapeutics Inc (RAPT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of RAPT Therapeutics Inc is 11.19%, while institutional ownership is 82.32%. The most recent insider transaction that took place on Jan 05 ’24, was worth 20,456. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 898 shares at a rate of $22.78, taking the stock ownership to the 27,820 shares. Before that another transaction happened on Dec 21 ’23, when Company’s Chief Medical Officer sold 2,500 for $21.68, making the entire transaction worth $54,200. This insider now owns 15,020 shares in total.
RAPT Therapeutics Inc (RAPT) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 17.89% per share during the next fiscal year.
RAPT Therapeutics Inc (NASDAQ: RAPT) Trading Performance Indicators
Check out the current performance indicators for RAPT Therapeutics Inc (RAPT). In the past quarter, the stock posted a quick ratio of 8.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.12, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -1.76 in one year’s time.
Technical Analysis of RAPT Therapeutics Inc (RAPT)
Looking closely at RAPT Therapeutics Inc (NASDAQ: RAPT), its last 5-days average volume was 2.05 million, which is a jump from its year-to-date volume of 0.75 million. As of the previous 9 days, the stock’s Stochastic %D was 58.81%. Additionally, its Average True Range was 0.39.
During the past 100 days, RAPT Therapeutics Inc’s (RAPT) raw stochastic average was set at 17.66%, which indicates a significant decrease from 22.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 237.03% in the past 14 days, which was higher than the 121.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.97, while its 200-day Moving Average is $6.06. However, in the short run, RAPT Therapeutics Inc’s stock first resistance to watch stands at $1.95. Second resistance stands at $2.15. The third major resistance level sits at $2.47. If the price goes on to break the first support level at $1.43, it is likely to go to the next support level at $1.10. Should the price break the second support level, the third support level stands at $0.90.
RAPT Therapeutics Inc (NASDAQ: RAPT) Key Stats
There are currently 34,903K shares outstanding in the company with a market cap of 56.94 million. Presently, the company’s annual sales total 0 K according to its annual income of -116,800 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -27,660 K.
